Nephrology and urology devices are commonly used for treatment of kidney and urinary system related problems such as chronic kidney disease (CKD) and end stage renal disease (ESRD), kidney stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. A slow growing awareness of urinary diseases and causes of renal failure has led to a large population suffering from CKD, diabetes and ESRD. Growing market for dialysis due to rising incidences of chronic kidney diseases (CKD) along with increasing aging population is the major driver for this market. Increasing awareness about the benefits such as reduced treatment and recovery time among renal disease patients is also influencing the demand for nephrology and urology devices. Some other driving factors include innovation in urology devices, increasing healthcare spending and growing refurbished devices market particularly for lithotripters in Asia-Pacific and other developing regions. This also leaves consumers in Europe and North America to revamp their clinics and hospitals with new innovative technologies.
Aging is the most common factor responsible for all types of urology diseases. It is expected that a large size of population will undergo kidney disease treatment which will increase the demand for these devices across the world. The U.S. National Institute of Diabetes and Digestive and Kidney Diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S. Continuously improving economic conditions in India, China and Australia will support these countries to invest significant amounts in advanced healthcare technologies and devices to improve the overall quality of life. Hospitals and healthcare providers are investing in cutting-edge technologies and devices due to the rising medical tourism industry particularly in Asian and Middle-East countries. No or less medical devices reimbursement to purchase new devices and technologies is the major challenge for the market growth in emerging markets. Benign Prostatic Hyperplasia is estimated to affect over 70% of men above the age of 60. BPH is a major concern for aged males and urinary incontinence is an embarrassing phenomenon for most people. Thus the market for treatment of these conditions is expected to grow through the forecast period.
The demand for minimally invasive procedures for the treatment of nephrology & urology diseases is growing at a faster pace due to both cost and clinical benefits over conventional treatment methods. Endoscopy’s visual ability to control and manage the minimally invasive treatments more effectively is motivating physicians to use this technology for the treatment of urology diseases such as kidney stone and BPH. The market growth is also expected to be fuelled with increasing demand for advanced technology devices such as video-endoscope and capsule endoscope.
Dialysis devices are currently dominating in the overall nephrology and urology devices market and BPH treatment devices represents the fastest growing segment in this market. Fresenius was the market leader in dialysis devices followed by Gambro and Baxter Corporation. In terms of geography, Europe is currently dominating in this market and is expected to hold its dominating position though the estimated forecast period with rising demands for minimally invasive procedures for treatment of renal diseases. Asia-Pacific represents the fastest growing regional economy in this market.
Nephrology and urology are the branches of medical science that deal with the study of kidney and urinary system, diseases and complications associated with it, their diagnosis (using variety of equipment) and types of treatment used to treat these complications. Nephrology, in particular, deals with kidney and urology deals with entire urinary system. The U.S. National Institute of Diabetes and Digestive and Kidney Diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S. This high prevalence of kidney and urinary system diseases is likely to support the growth of this market during the forecast period from 2012 to 2018.
The nephrology and urology devices market report analyzes current dynamics and trends in the global nephrology and urology devices market for the period from 2010 to 2018 and forecasts the market from 2012 to 2018, considering 2011 as the base year. The study provides details of the nephrology and urology devices used for the treatment of diseases of kidney and urinary system such as kidney and renal failure, urinary stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. The report also highlights role of endoscopy devices in nephrology and urology treatments.
The market of nephrology and urology devices is segmented on the basis of types of devices, such as, dialysis devices, urinary stone treatment devices, urinary incontinence & pelvic organ prolapse treatment devices, benign prostatic hyperplasia (BPH) devices, and endoscopy devices. Dialysis devices segment was the largest segment of this market in 2011, whereas, ‘BPH devices’ is estimated to be the fastest growing segment during the forecast period from 2012 to 2018. The market of these devices is estimated in terms of value in USD million. The in-depth segmentation of the market provides current trends and future outlook of technologies used for the treatment of nephrology and urology diseases. Additionally, the nephrology and urology devices market is segmented on the basis of major geographical regions such as North America, Europe, Asia-Pacific and Rest of the world (RoW) and is estimated in terms of USD million. From the regional analysis of the market, the European region is estimated as the largest regional market in the world, whereas, Asia-Pacific market is estimated to be the fastest growing market during the forecast period from 2012 to 2018. The growth of Asia-Pacific is likely to be supported by strong adoption potential for advanced technologies, due to rapidly growing awareness about technology and medical infrastructure, in this region.
The market overview section of the report highlights the market dynamics, such as, drivers, restraints and opportunities. Additionally, various analyses such as, Porter’s five forces analysis and market attractiveness analysis would help to understand the current and future scenario of the market more thoroughly.
The market share analysis section of the report provides the state of competition amongst key players present in the market. The recommendation section of the study provides overview of key market winning strategies and market barriers to be considered by new entrants as well as existing players. In addition, report also gives recommendations for industry players across the value chain based on current market trends and future outlook of this market.
The report also profiles leading players in this market on the basis of attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. The study will help manufacturers, suppliers and distributors in nephrology and urology devices industry to formulate and develop their strategies. The report contains company profiles of major players such as Asahi Kasei Corp, B. Braun Group, Baxter International, Inc., C. R. Bard Inc., Cook Group Incorporated, Dornier Medtech, Fresenius Medical Care, Nikkiso Co., Ltd., Nipro Corporation, Nxstage Medical Inc., Terumo Corporation, and Rockwell Medical Technologies, Inc.